Compare Quanta Services Inc (PWR) vs GeneDx Holdings Corp (WGS) Price & Performance

PWR trades at $685.33, down 2.25% today but maintains strong technical momentum with bullish moving averages and support at $684. The company demonstrates robust fundamentals with revenue growth from $23.7B to $28.5B in 2025 and consistent earnings beats, while analyst sentiment remains overwhelmingly positive with 27 buy ratings and a $802.08 consensus target.

PWR offers compelling growth exposure to infrastructure and AI-driven data center demand, supported by a record $53B backlog and margin expansion potential. Key risks include execution challenges on large projects and sensitivity to economic cycles, but strong institutional support and positive earnings momentum suggest continued upside potential.

GeneDx (WGS) trades at $67.73, down 1.17% today, showing mixed signals with bearish technical indicators but strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating expectations, and returned to adjusted profitability early. However, 2026 fundamentals show concerning trends with a net loss of $106 million and negative profit margins. Recent news highlights product innovations and leadership recognition, while technical analysis indicates the stock is trading near key support at $66.

The investment outlook presents a dichotomy between strong analyst conviction (90.9% buy ratings, $81 consensus target) and challenging fundamentals. While operational improvements and genomic testing growth offer potential upside, persistent losses and negative cash flow trends create significant execution risk. The stock's current position near support levels combined with oversold RSI readings suggests potential for near-term bounce, but sustainable gains require meaningful profitability improvements.